NEW YORK, March 15, 2023 /PRNewswire/ --

If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:

Joshua Rubin, Esq.
Weiss Law
305 Broadway, 7th Floor
New York, NY 10007
(212) 682-3025
(888) 593-4771
[email protected]

Shore Bancshares, Inc. (NASDAQ: SHBI)

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Shore Bancshares, Inc. (NASDAQ: SHBI), in connection with the proposed merger of SHBI with The Community Financial Corporation. If you own SHBI shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/shbi

Catalyst Biosciences, Inc. (NASDAQ: CBIO)

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Catalyst Biosciences, Inc. (NASDAQ: CBIO), in connection with the proposed purchase of GNI Group Ltd.'s ("GNI") proprietary new chemical entity F351 ("F351"). This purchase will transfer the global rights to F351 (excluding Mainland China) to CBIO in consideration of 6,266,521 shares of common stock and 12,340 shares of a new series of preferred stock ("Series X") with economic rights equivalent to CBIO common stock to be paid for GNI's 65.18% interest of Beijing Continent, a China based commercial-stage pharmaceutical company marketing pirfenidone and having the rights to F351 in China. If you own CBIO shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/cbio

TravelCenters of America Inc. (NASDAQ: TA)

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of TravelCenters of America Inc. (NASDAQ: TA) in connection with the proposed acquisition of TA by BP p.l.c. Under the terms of the merger agreement, TA shareholders will receive $86.00 in cash for each share of TA common stock owned. If you own TA shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/ta

Cardiovascular Systems, Inc. (NASDAQ: CSII)

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Cardiovascular Systems, Inc. (NASDAQ: CSII), in connection with the proposed acquisition of CSII by Abbott Laboratories. Under the terms of the merger agreement, CSII shareholders will receive $20.00 in cash for each share of CSII owned. If you own CSII shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/csii

View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-weiss-law-reminds-shbi-cbio-ta-and-csii-shareholders-about-its-ongoing-investigations-301773164.html

SOURCE Weiss Law